EZH2 and breast carcinoma: Li et al. found that PRMT1-mediated EZH2 (a potentiator of essential histone methyltransferase and EMT inducer, zeste homolog 2)-R342 methylation enhanced EZH2 stability, promoting breast cancer cell metastasis.